Related Experiment Videos

A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell

K Kobayashi1, T Ohye, I Pastan

  • 1Institute for Comprehensive Medical Science, School of Medicine, Fujita Health University, Aichi, Japan.

Nucleic Acids Research
|September 15, 1996
PubMed

Insights

Immunotoxoin-mediated cell targeting (IMCT) effectively eliminated specific mouse embryonic stem (ES) cells expressing a targeted receptor. This demonstrates IMCT

Area of Science:

  • Stem cell biology
  • Molecular biology
  • Immunology

Background:

  • Immunotoxoin-mediated cell targeting (IMCT) uses recombinant immunotoxins to eliminate specific cell types.
  • Mouse embryonic stem (ES) cells are crucial for developmental biology research and therapeutic applications.

Purpose of the Study:

  • To evaluate the feasibility of IMCT for negative selection in mouse ES cells.
  • To assess the efficacy of anti-Tac(Fv)-PE40 in targeting ES cells expressing the human interleukin-2 receptor alpha subunit.

Main Methods:

  • Utilized recombinant immunotoxin anti-Tac(Fv)-PE40 for targeted cell ablation.
  • Investigated the responsiveness of mouse ES cells engineered to express the human interleukin-2 receptor alpha subunit.

Main Results:

  • The immunotoxin treatment selectively eliminated ES cells that expressed the target receptor.
  • Confirmed the target specificity of anti-Tac(Fv)-PE40 in the context of mouse ES cells.

Conclusions:

  • IMCT is a viable strategy for negative selection of specific cell populations in mouse ES cells.
  • This technique can be employed for enriching ES cell clones with desired genetic modifications.

Related Concept Videos